- Home
- TEI vs NKTR Comparison
TEI vs NKTR Comparison
Compare TEI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEI
- NKTR
- Stock Information
- Founded
- TEI 1993
- NKTR 1990
- Country
- TEI United States
- NKTR United States
- Employees
- TEI N/A
- NKTR N/A
- Industry
- TEI Finance Companies
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- TEI Finance
- NKTR Health Care
- Exchange
- TEI Nasdaq
- NKTR Nasdaq
- Market Cap
- TEI 265.9M
- NKTR 108.3M
- IPO Year
- TEI N/A
- NKTR 1994
- Fundamental
- Price
- TEI $6.13
- NKTR $24.31
- Analyst Decision
- TEI
- NKTR Strong Buy
- Analyst Count
- TEI 0
- NKTR 6
- Target Price
- TEI N/A
- NKTR $77.50
- AVG Volume (30 Days)
- TEI 142.4K
- NKTR 4.4M
- Earning Date
- TEI 01-01-0001
- NKTR 08-07-2025
- Dividend Yield
- TEI 10.51%
- NKTR N/A
- EPS Growth
- TEI N/A
- NKTR N/A
- EPS
- TEI N/A
- NKTR N/A
- Revenue
- TEI N/A
- NKTR $87,248,000.00
- Revenue This Year
- TEI N/A
- NKTR N/A
- Revenue Next Year
- TEI N/A
- NKTR N/A
- P/E Ratio
- TEI N/A
- NKTR N/A
- Revenue Growth
- TEI N/A
- NKTR N/A
- 52 Week Low
- TEI $4.35
- NKTR $6.48
- 52 Week High
- TEI $5.39
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- TEI 76.13
- NKTR 68.55
- Support Level
- TEI $5.84
- NKTR $8.27
- Resistance Level
- TEI $5.86
- NKTR $37.38
- Average True Range (ATR)
- TEI 0.07
- NKTR 3.54
- MACD
- TEI 0.01
- NKTR 1.72
- Stochastic Oscillator
- TEI 93.94
- NKTR 55.75
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.